SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden

Recruiting Observational Study
Tick-Borne Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 and older
Sex
Any
Study type
Observational
Participants needed
600 (estimated)
Sponsor
Region Jönköping County · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria in TBD and Non-TBD groups: * Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results) Exclusion Criteria: * Incapacitated to understand the study information and make decisions (adul…
Contacts

Anna J Henningsson, Senior Associate Professor

46 10 242 12 26

anna.jonsson.henningsson@rjl.se

CONTACT

Johanna Sjöwall, Associate Professor (docent)

46 10 104 08 94

johanna.sjowall@liu.se

CONTACT